Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Human Anti-big-ET-1 Recombinant Antibody (HPAB-AP266-YC)


Creative Biolabs logo
View Antibody details

Human Anti-big-ET-1 Recombinant Antibody (HPAB-AP267-YC)


Creative Biolabs logo
View Antibody details

Human Anti-big-ET-1 Recombinant Antibody (HPAB-AP268-YC)


Creative Biolabs logo
View Antibody details

Human Anti-big-ET-1 Recombinant Antibody (HPAB-AP269-YC)


Creative Biolabs logo
View Antibody details

Human Anti-Blood Group B Recombinant Antibody (ABO.B1)


Creative Biolabs logo
View Antibody details

Human Anti-Blood group HI Recombinant Antibody (ABO.HI1)


Creative Biolabs logo
View Antibody details

Human Anti-Blood-brain barrier Recombinant Antibody (HPAB-0110-YJ)


Creative Biolabs logo
View Antibody details

Human Anti-Blood-brain barrier Recombinant Antibody (HPAB-0111-YJ)


Creative Biolabs logo
View Antibody details

Human Anti-BMP2 Recombinant Antibody (clone 11F2)


Creative Biolabs logo
View Antibody details

Human Anti-BMP2 Recombinant Antibody (clone 8B3)


Creative Biolabs logo
View Antibody details